4//SEC Filing
Sassi Nir 4
Accession 0001493152-22-005611
CIK 0001857044other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:30 PM ET
Size
5.4 KB
Accession
0001493152-22-005611
Insider Transaction Report
Form 4
Sassi Nir
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-25+60,000→ 60,000 totalExercise: $4.18Exp: 2032-02-25→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on February 25, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001760673
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:30 PM ET
- Size
- 5.4 KB